Differences in the JAK2 and MPL Mutation Status in the Cell Lineages of the bcr/abl-negative Chronic Myeloproliferative Neoplasm Subtypes-Reference-Cited by-同舟云学术

Differences in the JAK2 and MPL Mutation Status in the Cell Lineages of the bcr/abl-negative Chronic Myeloproliferative Neoplasm Subtypes

Published:2011 Issue:21 Volume:50 Page:2557-2561
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Toyama Kohtaro¹,Karasawa Masamitsu¹²,Yokohama Akihiko¹,Mitsui Takeki¹,Uchiumi Hideki¹,Saitoh Takayuki¹³,Handa Hiroshi¹,Murakami Hirokazu⁴,Nojima Yoshihisa¹,Tsukamoto Norifumi¹³

Affiliation:

1. Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine, Japan

2. Blood Transfusion Service, Gunma University Graduate School of Medicine, Japan

3. Oncology Center, Gunma University Hospital, Japan

4. School of Health Sciences, Gunma University School of Medicine, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

http://www.jstage.jst.go.jp/article/internalmedicine/50/21/50_21_2557/_pdf

Reference21 articles.

1. 3. Pardanani A, Lasho TL, Finke C, et al. Extending Jak2V617F and MplW515 Mutation Analysis to Single Hematopoietic Colonies and B and T Lymphocytes. Stem Cells 25: 2358-2362, 2007.

2. Biclonal expansion and heterogeneous lineage involvement in a case of chronic myeloproliferative disease with concurrent MPLW515L/JAK2V617F mutation

3. JAK2-V617F mutation analysis of granulocytes and platelets from patients with chronic myeloproliferative disorders: advantage of studying platelets

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of JAK2 V617F, CALR, and MPL W515L Gene Mutations in Patients with Essential Thrombocythemia in Kurdistan Region of Iraq;The Korean Journal of Clinical Laboratory Science;2021-03-31

2. Systematization of analytical studies of polycythemia vera, essential thrombocythemia and primary myelofibrosis, and a meta-analysis of the frequency of JAK2, CALR and MPL mutations: 2000–2018;BMC Cancer;2019-06-17

3. Triple Negative Myeloproliferative Neoplasms - Sometimes Driver Mutations Stay Low-Key in Plain Sight;ROM BIOTECH LETT;2018

4. Molecular characterisation of triple negative essential thrombocythaemia patients by platelet analysis and targeted sequencing;Blood Cancer Journal;2016-08